Journal article
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk
Abstract
Identification and management of patients at high bleeding risk undergoing percutaneous coronary intervention are of major importance, but a lack of standardization in defining this population limits trial design, data interpretation, and clinical decision-making. The Academic Research Consortium for High Bleeding Risk (ARC-HBR) is a collaboration among leading research organizations, regulatory authorities, and physician-scientists from the …
Authors
Urban P; Mehran R; Colleran R; Angiolillo DJ; Byrne RA; Capodanno D; Cuisset T; Cutlip D; Eerdmans P; Eikelboom J
Journal
European Heart Journal, Vol. 40, No. 31, pp. 2632–2653
Publisher
Oxford University Press (OUP)
Publication Date
August 14, 2019
DOI
10.1093/eurheartj/ehz372
ISSN
0195-668X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Acute Coronary SyndromeAgedAged, 80 and overAnemiaAsiaClinical Decision-MakingClinical Trials as TopicConsensusDrug-Eluting StentsDual Anti-Platelet TherapyEuropeFibrosisFrailtyHemorrhageHumansHypertension, PortalMetalsPercutaneous Coronary InterventionRenal Insufficiency, ChronicRisk AssessmentSafetyStentsThrombocytopeniaTreatment OutcomeUnited StatesAssessment of Medication Adherence